Harbour Investments Inc. Has $3.86 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Harbour Investments Inc. grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 6,599 shares of the healthcare conglomerate’s stock after purchasing an additional 263 shares during the quarter. Harbour Investments Inc.’s holdings in UnitedHealth Group were worth $3,858,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Investment Management Associates Inc. ADV acquired a new position in UnitedHealth Group during the third quarter valued at approximately $219,000. Vantage Investment Partners LLC raised its stake in UnitedHealth Group by 2.6% during the 3rd quarter. Vantage Investment Partners LLC now owns 154,130 shares of the healthcare conglomerate’s stock worth $90,117,000 after buying an additional 3,909 shares during the period. Everhart Financial Group Inc. grew its stake in UnitedHealth Group by 19.5% in the third quarter. Everhart Financial Group Inc. now owns 4,628 shares of the healthcare conglomerate’s stock valued at $2,706,000 after acquiring an additional 754 shares during the period. FDx Advisors Inc. raised its position in shares of UnitedHealth Group by 22.0% during the third quarter. FDx Advisors Inc. now owns 1,180 shares of the healthcare conglomerate’s stock worth $690,000 after purchasing an additional 213 shares during the period. Finally, Lynx Investment Advisory increased its stake in UnitedHealth Group by 7.2% during the 3rd quarter. Lynx Investment Advisory now owns 880 shares of the healthcare conglomerate’s stock worth $514,000 after purchasing an additional 59 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $615.01 on Wednesday. The company has a market cap of $565.98 billion, a P/E ratio of 40.07, a P/E/G ratio of 1.84 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The firm’s fifty day moving average price is $582.63 and its two-hundred day moving average price is $546.78. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.56 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.37%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on UNH shares. TD Cowen upped their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. KeyCorp started coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 target price for the company. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Argus boosted their target price on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.